Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekrrCfbwocfbzdmlzbuu

  ADVERTISEMENT  
February 15, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
 
  • PRP linked to benefits for patients with knee osteoarthritis
    Platelet-rich plasma therapy improved pain and function scores for patients with knee osteoarthritis one year after the treatment, according to findings published in the Clinical Journal of Sport Medicine. The condition did not progress in 73% of cases. The study used magnetic resonance imaging and other evaluation tools to assess PRP results. Healio/Orthopedics Today (2/13) LinkedInFacebookTwitterEmail this Story
 
  ADVERTISEMENT  
Variety is the spice of life.
That's why Quotient sources cells from US, Europe and Asia for its new to the market antibody screens and ID panels, helping you rule out and rule in antibodies. GPOs must like variety too, because Quotient has new contracts with Premier, Amerinet and GSA, saving you money. Find out how the one company focused on manual testing can serve you in 2013 and beyond.

  Science & Health 
  • Study to explore stem cell therapy for diabetic retinopathy
    A European Union-supported study will explore the use of adult bone marrow stem cells in treating diabetic retinopathy. Researchers are set to grow the cells in the laboratory and plan to transplant them in patients in an attempt to repair damaged blood vessels and retinas and to restore vision. Human trials are slated to be conducted in Denmark after preclinical tests at several sites in Europe. Diabetes.co.uk (U.K.) (2/14) LinkedInFacebookTwitterEmail this Story
  • Researchers report progress with experimental dengue vaccine
    Researchers at the International Centre for Genetic Engineering and Biotechnology in New Delhi said they are making strides with a vaccine for the dengue virus, which is being developed with technology used to make hepatitis B vaccine. Preclinical tests showed the vaccine addressed all of the four dengue virus strains, researchers said. Human trials are estimated to be at least five years away. Deutsche Welle (Germany) (2/14) LinkedInFacebookTwitterEmail this Story
  • Experts tie chemotherapy to slight increase in AML risk
    Patients who underwent chemotherapy for non-Hodgkin lymphoma and esophageal, prostate and cervical cancers had an increased risk of developing acute myeloid leukemia, a study found. However, chemotherapy was associated with lower AML risk in ovarian cancer and myeloma, researchers said. HealthDay News (2/14) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • Study assesses radiation exposure before kidney transplant
    A new study that evaluates exposure to medical imaging ionizing radiation among patients during procedures ahead of kidney transplantation finds that nuclear stress testing accounts for the majority of overall radiation exposure. The research was published in the Clinical Journal of the American Society of Nephrology. "The effects of radiation upon malignancy risk and strategies to reduce this radiation exposure warrant further investigation," according to researchers. Renal and Urology News (2/12) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  Government & Regulatory 
  • Federal officials make the case for EHR usability
    EHRs need to be usable, benefit doctors and work within the health care facility's systems so as not to waste the investment made on these technologies, officials with the ONC and National Institute of Standards and Technology said at a recent conference. Meaningful use certification and keeping the provider end-user in mind when designing EHRs are some ways to achieve EHR usability, they said. Healthcare IT News (2/12) LinkedInFacebookTwitterEmail this Story
  Association News 
  • AABB releases rates for 2013 Annual Meeting and CTTXPO
    AABB has released the registration and housing rates for the 2013 Annual Meeting and CTTXPO, which will be held in Denver. Registration and housing opens June 5 for AABB members and June 26 for general attendees. More information is available online. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Donor Collections DirectorBlood Centers of the PacificUS - CA - San Francisco
Medical Technologist CLS - Cord Blood ProgramSan Diego Blood BankUS - CA - San Diego
Click here to view more job listings.

  SmartQuote 
If you want to live a happy life, tie it to a goal. Not to people or things."
--Albert Einstein,
German-born theoretical physicist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information